ImmunoGen, Inc. Earnings: What Goes Up, Must Come Down

ImmunoGen, Inc. Earnings: What Goes Up, Must Come Down

After popping 14% on Friday follow earnings that didn't justify the increase, shares of ImmunoGen (NASDAQ: IMGN) are down 12.6% at 2:49 p.m. EDT on Monday, also for no apparent reason. The biotech reported second-quarter earnings on Friday, but without any revenue-generating drugs on the market, the focus is on the biotech's pipeline rather than the earnings number.

Metric

Q2 2017

Continue reading

Source: Fool.com